Loading
Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Shanghai · hospital | China | none recorded | 0 | 2,872 | 31,534 | - | |
Cambridge · hospital | United Kingdom | none recorded | 0 | 931 | 11,659 | - | |
Rotterdam · cancer center | Netherlands | none recorded | 0 | 875 | 12,592 | - | |
| Switzerland | none recorded | 0 | 470 | 4,598 | - | ||
Munich · university | Germany | none recorded | 0 | 438 | 4,021 | - | |
Chandigarh · hospital | India | none recorded | 0 | 398 | 3,509 | - | |
São Paulo · cancer center | Brazil | none recorded | 0 | 354 | 2,437 | - | |
London · hospital | United Kingdom | none recorded | 0 | 318 | 3,038 | - | |
Uppsala · hospital | Sweden | none recorded | 0 | 211 | 1,236 | - | |
Madrid · research institute | Spain | none recorded | 0 | 201 | 3,539 | - | |
Rehovot · research institute | Israel | none recorded | 0 | 183 | 3,727 | - | |
Belfast · hospital | United Kingdom | none recorded | 0 | 173 | 1,217 | - | |
Glasgow · hospital | United Kingdom | none recorded | 0 | 159 | 2,693 | - | |
Brno · cancer center | Czechia | none recorded | 0 | 155 | 1,946 | - | |
Manchester · hospital | United Kingdom | none recorded | 0 | 144 | 1,630 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Grade 3 well-differentiated neuroendocrine tumour but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.